Cargando…

Effect of Vaccination against SARS-CoV-2 on Long COVID-19: A Narrative Review

Vaccines against SARS-CoV-2 have saved millions of lives and played an important role in containing the COVID-19 pandemic. Vaccination against SARS-CoV-2 is also associated with reduced disease severity and, perhaps, with COVID-19 symptom burden. In this narrative review, we present, in a clinically...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tofarides, Andreas G., Christaki, Eirini, Milionis, Haralampos, Nikolopoulos, Georgios K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785763/ https://www.ncbi.nlm.nih.gov/pubmed/36556422 http://dx.doi.org/10.3390/life12122057

Ejemplares similares

Anakinra in COVID-19: A step closer to the cure
por: Barkas, Fotios, et al.
Publicado: (2022)

Circulating IgG Levels in SARS-CoV-2 Convalescent Individuals in Cyprus
por: Mamais, Ioannis, et al.
Publicado: (2021)

Factors Associated with Extended-Spectrum β-Lactamases and Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections: A Five-Year Retrospective Study
por: Tofarides, Andreas G., et al.
Publicado: (2023)

Influenza Virus—Host Co-evolution. A Predator-Prey Relationship?
por: Voskarides, Konstantinos, et al.
Publicado: (2018)

A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine
por: Moutsopoulos, Haralampos M.
Publicado: (2021)

Gaps in Knowledge About SARS-CoV-2 & COVID-19 Among University Students Are Associated With Negative Attitudes Toward People With COVID-19: A Cross-Sectional Study in Cyprus
por: Middleton, Nicos, et al.
Publicado: (2021)

Multicentre Surveillance of Candida Species from Blood Cultures during the SARS-CoV-2 Pandemic in Southern Europe (CANCoVEU Project)
por: Boattini, Matteo, et al.
Publicado: (2023)

Association of patient characteristics with clinical outcomes in a cohort of hospitalised patients with SARS-CoV-2 infection in a Greek referral centre for COVID-19
por: Rapti, I., et al.
Publicado: (2022)

Association of patient characteristics with clinical outcomes in a cohort of hospitalised patients with SARS-CoV-2 infection in a Greek referral centre for COVID-19 – Corrigendum
por: Rapti, I., et al.
Publicado: (2023)

An update on vaccine status and the role of nanomedicine against SARS‐CoV‐2: A narrative review
por: Tajnur, Rabeya, et al.
Publicado: (2023)

Timing vaccination against SARS-CoV-2
por: Barnoud, Coline, et al.
Publicado: (2021)

T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
por: Liu, William J., et al.
Publicado: (2017)

Timely development of vaccines against SARS-CoV-2
por: Lu, Shan
Publicado: (2020)

Recombinant protein vaccines against SARS-CoV-2
por: Gilbert, Sarah C, et al.
Publicado: (2021)

Messenger RNA vaccines against SARS-CoV-2
por: Topol, Eric J.
Publicado: (2021)

Development of an Inactivated Vaccine against SARS CoV-2
por: Pavel, Shaikh Terkis Islam, et al.
Publicado: (2021)

Vaccination of susceptible animals against SARS-CoV-2
por: Xiang, Bin, et al.
Publicado: (2022)

Nucleic Acid Vaccines against SARS-CoV-2
por: Liu, Ying, et al.
Publicado: (2022)

The development of DNA vaccines against SARS-CoV-2
por: Khalid, Kanwal, et al.
Publicado: (2023)

Long-term observation of antibody titers against SARS-CoV-2 following vaccination
por: Sugiyama, Kazuo, et al.
Publicado: (2022)

Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
por: Fiolet, Thibault, et al.
Publicado: (2022)

Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
por: Gómez, Carmen Elena, et al.
Publicado: (2021)

SARS-CoV-2 and COVID-19: A Narrative Review
por: Blann, A. D., et al.
Publicado: (2022)

Vaccines and Vaccination against SARS-CoV-2: Considerations for the Older Population
por: Weinberger, Birgit
Publicado: (2021)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
por: Chao, Chiao-Hsuan, et al.
Publicado: (2022)

Next-Generation Vaccines: Nanovaccines in the Fight against SARS-CoV-2 Virus and beyond SARS-CoV-2
por: Mufamadi, Maluta Steven, et al.
Publicado: (2023)

NVX-CoV2373, a protein-based vaccine against SARS-CoV-2 infection
por: Vohra-Miller, Sabina, et al.
Publicado: (2022)

Progress and Prospects on Vaccine Development against SARS-CoV-2
por: Zhang, Jinyong, et al.
Publicado: (2020)

Identification of synthetic vaccine candidates against SARS CoV infection
por: Lien, Shu-Pei, et al.
Publicado: (2007)

Correlates of Vaccine-Induced Protection against SARS-CoV-2
por: Koch, Till, et al.
Publicado: (2021)

Decisive Conditions for Strategic Vaccination against SARS-CoV-2
por: Böttcher, Lucas, et al.
Publicado: (2021)

Should we vaccinate children against SARS-CoV-2?
por: The Lancet Infectious Diseases
Publicado: (2021)

Targets and strategies for vaccine development against SARS-CoV-2
por: Malik, Jonaid Ahmad, et al.
Publicado: (2021)

The Uro-oncology Patient and Vaccination Against SARS-CoV-2
por: Rodriguez Socarrás, Moises, et al.
Publicado: (2021)

Are the new SARS-CoV-2 variants resistant against the vaccine?
por: Abdalla, Mohnad, et al.
Publicado: (2021)

Comparison of replicating and nonreplicating vaccines against SARS-CoV-2
por: Mudrick, Haley E., et al.
Publicado: (2022)

Development of DNA Vaccine Candidate against SARS-CoV-2
por: Wang, Xingyun, et al.
Publicado: (2022)

Hashimoto encephalopathy after vaccination against SARS-CoV-2
por: Viscasillas Sancho, M., et al.
Publicado: (2022)

SARS CoV- 2 vaccination induces antibodies against cardiolipin
por: Krashias, George, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_312digti5t2gkslv8d3t470m6c